Literature DB >> 26137285

Outcome of papillary thyroid microcarcinoma: Study of 1,990 cases.

Zhong-Zhi Lu1, Yan Zhang2, Song-Feng Wei2, Dong-Sheng Li1, Qing-Hua Zhu1, Si-Jing Sun1, Min Li1, L I Li1.   

Abstract

The present study examines the requirement of prophylactic neck node dissection in papillary thyroid microcarcinoma (PTMC) patients by analyzing high-risk factors of neck lymph node metastasis in PTMC. The clinical pathological data was a review of 1,990 patients diagnosed between January 2013 and January 2014. The data included information on patient gender, age, tumor size, multifocal, tumor pathological staging, bilateral thyroid cancer, the subtypes, BRAFV600E mutation, human telomerase reverse transcriptase (hTERT), extrathyroidal invasion and neck lymph node metastasis. The univariate analysis (χ2 test) showed that a number of factors were significantly associated with neck lymph node metastasis in PTMC (P<0.05): Male gender, aged <45 years, extrathyroidal invasion, bilateral thyroid cancer, various subtypes (package type, follicular variant, diffuse sclerosing variant, eosinophils, tall cell and column variant), BRAFV600E mutation-positive, hTERT mutation-positive, pt3/4 and multifocality. The multivariate analysis (regression binary logistic) showed that the male gender, <45 years, tumor size >5 mm, extrathyroidal invasion, bilateral thyroid tumors, multifocality, BRAFV600E mutation-positive, hTERT mutation-positive and pt3/4 are associated with the neck lymph node metastasis in PTMC (P<0.05). These paired analysis results show that the subtypes of PTMC with tumor size >5 mm is more common than the specific types of PTMC in which the tumor is ≤5 mm in neck lymph node metastasis. The neck lymph node metastasis incidence of the >45 years age group patients without high-risk factors in PTMC is 8.13 and 6.80%, respectively. In conclusion, PTMC patients with high-risk factors only are recommended to undergo a prophylactic lymph node dissection.

Entities:  

Keywords:  neck lymph node dissection; neck lymph node metastasis; papillary thyroid microcarcinoma; risk factors

Year:  2015        PMID: 26137285      PMCID: PMC4471526          DOI: 10.3892/mco.2015.495

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  23 in total

1.  Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas.

Authors:  Ryan P McCarthy; Mingsheng Wang; Timothy D Jones; Randall W Strate; Liang Cheng
Journal:  Clin Cancer Res       Date:  2006-04-15       Impact factor: 12.531

2.  Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.

Authors:  Bon Seok Koo; Eun Chang Choi; Yeo-Hoon Yoon; Dong-Hyun Kim; Eung-Hyub Kim; Young Chang Lim
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

3.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

4.  Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  F Pacini; M G Castagna; L Brilli; G Pentheroudakis
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

5.  Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Authors:  David G Pfister; Sharon Spencer; David M Brizel; Barbara Burtness; Paul M Busse; Jimmy J Caudell; Anthony J Cmelak; A Dimitrios Colevas; Frank Dunphy; David W Eisele; Jill Gilbert; Maura L Gillison; Robert I Haddad; Bruce H Haughey; Wesley L Hicks; Ying J Hitchcock; Antonio Jimeno; Merrill S Kies; William M Lydiatt; Ellie Maghami; Renato Martins; Thomas McCaffrey; Loren K Mell; Bharat B Mittal; Harlan A Pinto; John A Ridge; Cristina P Rodriguez; Sandeep Samant; David E Schuller; Jatin P Shah; Randal S Weber; Gregory T Wolf; Frank Worden; Sue S Yom; Nicole R McMillian; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2014-10       Impact factor: 11.908

6.  The WHO histological classification of thyroid tumors: a commentary on the second edition.

Authors:  C Hedinger; E D Williams; L H Sobin
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

7.  Revisiting the guidelines issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: a gradual move towards consensus between Japanese and western practice in the management of thyroid carcinoma.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Naoyoshi Onoda; Hitoshi Noguchi; Akira Yoshida
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

8.  An observational trial for papillary thyroid microcarcinoma in Japanese patients.

Authors:  Yasuhiro Ito; Akira Miyauchi; Hiroyuki Inoue; Mitsuhiro Fukushima; Minoru Kihara; Takuya Higashiyama; Chisato Tomoda; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya
Journal:  World J Surg       Date:  2010-01       Impact factor: 3.352

9.  Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.

Authors:  Giuseppe Mercante; Andrea Frasoldati; Corrado Pedroni; Debora Formisano; Luigi Renna; Simonetta Piana; Giorgio Gardini; Roberto Valcavi; Verter Barbieri
Journal:  Thyroid       Date:  2009-07       Impact factor: 6.568

10.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

View more
  15 in total

1.  Natural History of Asymptomatic Papillary Thyroid Microcarcinoma: Time-Dependent Changes in Calcification and Vascularity During Active Surveillance.

Authors:  Ashwini Reddy; Sabaretnam Mayilvaganan
Journal:  World J Surg       Date:  2016-11       Impact factor: 3.352

2.  Insight into Differentiated Thyroid Cancer Gross Pathological Specimen Shrinkage and Its Influence on TNM Staging.

Authors:  Alexis Lacout; Emmanuel Chamorey; Juliette Thariat; Mostafa El Hajjam; Carole Chevenet; Renaud Schiappa; Pierre Yves Marcy
Journal:  Eur Thyroid J       Date:  2017-07-26

3.  Is papillary thyroid microcarcinoma an indolent tumor?: A retrospective study on 280 cases treated with radioiodine.

Authors:  Xuemei Gao; Xiao Zhang; Yajing Zhang; Wenjuan Hua; Yusufu Maimaiti; Zairong Gao
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

4.  Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: Analysis of 66 cases that underwent central and lateral lymph node dissection.

Authors:  Yang Tao; Chongjie Wang; Liye Li; Haijun Xing; Yun Bai; Bing Han; Zhiyan Liu; Xiangshan Yang; Shourong Zhu
Journal:  Mol Clin Oncol       Date:  2016-11-18

Review 5.  The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review.

Authors:  Huy Gia Vuong; Ahmed M A Altibi; Amr Hesham Abdelhamid; Phuong Uyen Duong Ngoc; Vo Duy Quan; Mohamed Yousef Tantawi; Mohamed Elfil; Tran Le Huy Vu; Ahmed Elgebaly; Naoki Oishi; Tadao Nakazawa; Kenji Hirayama; Ryohei Katoh; Nguyen Tien Huy; Tetsuo Kondo
Journal:  Oncotarget       Date:  2017-02-07

6.  Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.

Authors:  Jingtai Zhi; Jingzhu Zhao; Ming Gao; Yi Pan; Jianghua Wu; Yigong Li; Dapeng Li; Yang Yu; Xiangqian Zheng
Journal:  Int J Clin Oncol       Date:  2017-07-25       Impact factor: 3.402

7.  Model of lymph node metastasis posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma.

Authors:  Yi Luo; Xiao-Cheng Xu; Jie Shen; Jing-Jing Shi; Si Lu; Wei He; Jian-Yong Lei; Ding-Cun Luo
Journal:  Cancer Manag Res       Date:  2018-08-06       Impact factor: 3.989

8.  Incidental Papillary Thyroid Microcarcinoma in an Endemic Goiter Area.

Authors:  Emin Gürleyik; Gunay Gurleyik; Banu Karapolat; Ufuk Onsal
Journal:  J Thyroid Res       Date:  2016-02-02

Review 9.  A meta-analysis on the effect of operation modes on the recurrence of papillary thyroid microcarcinoma.

Authors:  Dandan Yi; Peng Song; Tao Huang; Xiaoqiao Tang; Jianfeng Sang
Journal:  Oncotarget       Date:  2017-01-24

10.  Diagnostic significance of CK19, galectin-3, CD56, TPO and Ki67 expression and BRAF mutation in papillary thyroid carcinoma.

Authors:  Lihua Huang; Xuming Wang; Xuan Huang; Huawei Gui; Yan Li; Qiongxia Chen; Dongling Liu; Lijiang Liu
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.